Publications by authors named "Amal Sharfi"
Article Synopsis
- Ivabradine is recommended for patients with heart failure (HF) to lower the risk of cardiovascular death and hospitalization from worsening symptoms, specifically in those with a heart rate over 70 bpm and reduced ejection fraction.
- The study, conducted on 111 HF patients, compared outcomes between those treated with ivabradine and those without; results indicated a lower hospitalization risk for the ivabradine group, although the difference wasn't statistically significant.
- Conclusions show that while ivabradine may reduce hospitalization risk in HF patients, it did not significantly affect the overall mortality rate compared to the standard treatment alone.
Background: Medication use review (MUR) is increasingly being recognized globally as a routine strategy performed by pharmacists to optimize the therapeutic outcomes of long-term medications. MUR services are not commonly available in hospitals and primary health care (PHC) centers in Qatar and no previous studies have reported the nature and extent of such services where they exist.
Objective: To describe the extent and types of drug-related problems (DRPs) generated from MUR interactions conducted at a PHC facility in Qatar and to determine the effect of patient characteristics on the number of DRPs.